Secondary Prevention

Revision as of 12:18, 7 August 2020 by TayyabaAli (talk | contribs)
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Jump to navigation Jump to search

Main article: Bartter syndrome

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]Associate Editor(s)-in-Chief: Tayyaba Ali, M.D.[2]

Overview

Main Careful monitoring is required since NSAIDs can have significant adverse effects including renal and gastrointestinal toxicity.

Secondary Prevention

Main Careful monitoring is required since NSAIDs can have significant adverse effects including renal and gastrointestinal toxicity.[1]

References

  1. Blanchard A, Vargas-Poussou R, Vallet M, Caumont-Prim A, Allard J, Desport E; et al. (2015). "Indomethacin, amiloride, or eplerenone for treating hypokalemia in Gitelman syndrome". J Am Soc Nephrol. 26 (2): 468–75. doi:10.1681/ASN.2014030293. PMC 4310664. PMID 25012174.